RecruitingNot Applicable

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

South Korea50,000 participantsStarted 2009-01

Plain-language summary

The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * coronary disease amenable to percutaneous coronary intervention (PCI) * no clinical and lesion limitations Exclusion Criteria: * patients with a mixture of several DES * terminal illness with life expectancy less than 1 year * patients with cardiogenic shock

What they're measuring

Composite of death, nonfatal myocardial infarction (MI), or ischemic-driven Target- Vessel Revascularization (TVR)

Timeframe: at 12 months post procedure

Trial details

NCT IDNCT01186133

SponsorSeung-Jung Park

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-12

Contact for this trial

Seung-Jung Park, MD

sjpark@amc.seoul.kr

View on ClinicalTrials.gov More Coronary Artery Disease trials